Medical Cannabis Evidence Map: Broad Promise, Variable Proof
The 2024 medical cannabis evidence map synthesizes 194 systematic reviews across 71 health outcomes, focusing on high-quality evidence. It highlights positive or potentially positive effects for pain, seizures, anxiety, and more. This map guides…
Cannabinoids Show Modest Promise for Cancer-Related Appetite Loss in Older Adults, But Evidence Remains Thin
Cannabinoid receptor type 1 activation plays a role in appetite regulation for older adults with cancer-related anorexia. Current evidence shows modest benefits but remains limited and inconclusive. Further research is needed to establish clinical…
Prevalence of Schizophrenia Spectrum and Bipolar Disorder Among Cannabis Induced Psychosis Patients
Cannabis induced psychosis risk is a critical clinical concern with significant implications for patient prognosis. This review provides prevalence data on progression to schizophrenia spectrum and bipolar disorder. Understanding this risk helps guide…
Impact of Preoperative Cannabis Use on Spinal Fusion Outcomes
This systematic review examines preoperative cannabis use spinal fusion and its impact on perioperative outcomes. Cannabis users undergoing spinal fusion require more opioids and face higher readmission and reoperation rates. Understanding these effects…
The Wake of Addiction: Pharmacological Approaches to Sleep Disturbances in Stimulant Use Disorders
This systematic review examines pharmacological strategies for sleep disturbances in stimulant use disorders. Sleep disruption is a critical factor in relapse and recovery. Effective management of sleep issues may enhance treatment success in stimulant…
What This Lancet Review Really Says About Cannabinoids in Psychiatry – CED Clinic
The cannabinoids mental health evidence from The Lancet review highlights mixed quality research with some promising findings. This review influences clinical guidelines and provider perspectives on cannabis therapeutics in psychiatry. Understanding this…
Cannabinoids for Mental Health: Large Review Finds Mostly Low-Quality Evidence With …
This cannabinoids mental health systematic review highlights the predominance of low-quality evidence in cannabis-based mental health treatments. It underscores the gap between patient demand and robust clinical data. Clinicians should counsel patients…
Lancet Review of Medical Cannabis in Mental Health – What the Study Shows
The Lancet review on mental health cannabis use evidence reveals a significant gap between clinical practice and research. Cannabis is increasingly used by patients with psychiatric disorders despite limited trial data. This review emphasizes the need…
Psychosocial Interventions for Substance Use Disorder: A Systematic Review of Therapeutic Approaches and Their Clinical Effectiveness.
Psychosocial interventions substance use disorder treatment are essential for effective care. This review highlights CBT and multicomponent approaches as most effective. Contingency management also shows promise for specific populations.
Cannabinoids Show Modest, Low-Certainty Benefits for a Few Mental Health Conditions—But Widespread Clinical Use Is Not Justified
This 2026 review examines cannabinoids mental health benefits, revealing modest effects for select conditions. Evidence remains limited and of low certainty. Routine clinical use is not justified without further trials.
